Details for New Drug Application (NDA): 218306
✉ Email this page to a colleague
The generic ingredient in LISDEXAMFETAMINE DIMESYLATE is lisdexamfetamine dimesylate. Fifteen suppliers are listed for this compound. Additional details are available on the lisdexamfetamine dimesylate profile page.
Summary for 218306
Tradename: | LISDEXAMFETAMINE DIMESYLATE |
Applicant: | Msn |
Ingredient: | lisdexamfetamine dimesylate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 218306
Physiological Effect | Central Nervous System Stimulation |
Medical Subject Heading (MeSH) Categories for 218306
Suppliers and Packaging for NDA: 218306
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 218306 | ANDA | Novadoz Pharmaceuticals LLC | 72205-132 | 72205-132-91 | 100 TABLET, CHEWABLE in 1 BOTTLE (72205-132-91) |
LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 218306 | ANDA | Novadoz Pharmaceuticals LLC | 72205-133 | 72205-133-91 | 100 TABLET, CHEWABLE in 1 BOTTLE (72205-133-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 10MG | ||||
Approval Date: | Feb 2, 2024 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 20MG | ||||
Approval Date: | Feb 2, 2024 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 30MG | ||||
Approval Date: | Feb 2, 2024 | TE: | AB | RLD: | No |
Complete Access Available with Subscription